News

FDA announces change to future Covid-19 vaccine approvals that will limit fall boosters
The agency is changing the standard of evidence required for Covid-19 vaccine approval in the US, Dr. Vinay Prasad, the new ...
FDA sets new COVID booster guidelines requiring trials for approvals for healthy adults
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...
Endpoints News3h
Makary, Prasad spell out FDA ground rules for fu­ture Covid vac­cine ap­provals
FDA chief Marty Makary and new CBER Director Vinay Prasad said that future Covid-19 vaccine approvals will focus on adults ...
STAT13d
Vinay Prasad, in his own words, outlines the philosophy he’ll bring to the FDA
Not Vinay Prasad. The new top regulator of vaccines and gene therapies at the Food and Drug Administration has never shied ...
Trump administration set to limit COVID-19 shot approvals to the elderly, highest-risk
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to adults over 65 and people who are high risk. The move is a significant shift ...
Axios on MSN12d
Vinay Prasad believes that the FDA too often has acted as a rubber stamp for pharma, both big and small.
Biotech venture capital is risky business, inherently at the mercy of regulators and binary outcomes. Now it may face a new ...
STAT3d
At gene therapy meeting, no one wants to talk about the Vinay Prasad (not) in the room
At the American Society of Cell and Gene Therapy conference, there were questions and qualms on how Vinay Prasad may change ...
Indian-origin Vinay Prasad becomes US' top vaccine official. Who is he? Why is he controversial?
Controversial oncoologist-haematologist Vinay Prasad will be the FDA's top vaccine regulator. Apart from his extensive ...
STAT3d
Day 3 at ASGCT: Vinay Prasad speculation, screening newborns, promising data
A hot (if cautious) topic at the big gene therapy meeting: what Vinay Prasad's appointment might mean for approvals in rare ...
Science-Based Medicine11dOpinion
Dr. Vinay Prasad is Now the Medical Establishment. It’s His Job to Run RCTs, and It’s Our Job to Call Him a Lying Piece of $#!& if He Fails.
From claiming COVID vaccines were perfect and would end the pandemic to treating rare, temporary vaccine side-effects, even ...
STAT12d
New CBER Director Vinay Prasad praises evidence, FDA reviewers in first speech to staff
WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his ...
MedPage Today on MSN12dOpinion
Vinay Prasad Speaks to CBER Staff: Which Prasad Showed Up?
The question on many minds among FDA rank-and-file in attendance was: Which Prasad would show up? The 2010s Prasad -- a ...